0001792522-25-000002.txt : 20251205 0001792522-25-000002.hdr.sgml : 20251205 20251205125624 ACCESSION NUMBER: 0001792522-25-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251205 DATE AS OF CHANGE: 20251205 EFFECTIVENESS DATE: 20251205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MindImmune Therapeutics, Inc. CENTRAL INDEX KEY: 0001792522 ORGANIZATION NAME: EIN: 812613707 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565904 FILM NUMBER: 251552147 BUSINESS ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 BUSINESS PHONE: 401-225-4612 MAIL ADDRESS: STREET 1: 130 FLAGG ROAD CITY: KINGSTON STATE: RI ZIP: 02881 D 1 primary_doc.xml X0708 D LIVE 0001792522 MindImmune Therapeutics, Inc. 130 FLAGG ROAD KINGSTON RI RHODE ISLAND 02881 401-225-4612 DELAWARE None None Corporation true Isaac Stoner 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Director CEO Bradley Margus 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Christopher O'Donnell 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Reetika Bhardwaj 130 Flagg Road Kingston RI RHODE ISLAND 02881 Director Robert Nelson 130 Flagg Road Kingston RI RHODE ISLAND 02881 Executive Officer Secretary Pharmaceuticals Decline to Disclose 06b false 2025-11-24 false true true false 0 12000000 10203858 1796142 The Issuer also converted previously issued promissory notes valued at $7,731,294 into shares of its Series A-3(A) Preferred Stock. false 14 0 0 0 true false MindImmune Therapeutics, Inc. /s/ Isaac Stoner Isaac Stoner CEO 2025-12-05